Stanley B. Fiel, MD
Regional Chairman, Department of Medicine
Atlantic Health System
deNeufville Professor and Chair
Department of Medicine
Morristown Memorial Hospital
Professor of Medicine
Drexel University College of Medicine
Frank Sciurba, MD, FCCP
Associate Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Pulmonary Physiology Laboratory
University of Pittsburgh School of Medicine
CME and CPE, 1 hour; Nursing and NP CE, 1.2 hours
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the US. Because smoking is the primary cause of COPD, it is a preventable disease. It incurs high healthcare costs through numerous physician office visits and hospitalizations.
COPD is a chronic, progressive disease characterized by airflow limitation and an abnormal inflammatory response of the lungs. It is commonly confused with asthma, especially among smokers. Asthma and COPD are different disorders, but have some common clinical and pathophysiological features. They can be differentially diagnosed based on clinical testing and history. Chronic bronchitis and emphysema are considered part of the COPD diagnosis.
Diagnosing COPD early is important because the symptoms, although potentially severely limiting, are very treatable. The World Health Organization's Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published updated versions of its guidelines to standardize diagnostic criteria and improve patient care.
This program will discuss the changing epidemiology of COPD as its prevalence continually increases. It will also review the inflammatory processes involved in COPD as well as the classification of COPD severity based on the GOLD guidelines. Importantly, this program will offer practical information for the primary care practitioner on recognizing and diagnosing COPD in the patient population, with particular emphasis on the role of lung function measurements. The importance of smoking cessation will also be discussed.
. Target Audience
Physicians, nurses, nurse practitioners, and pharmacists with an interest in COPD.
Upon completion of this educational activity, the participant should be able to:
Describe the role of inflammation in the pathogenesis of chronic obstructive pulmonary disease (COPD).
Discuss the changing epidemiology of COPD.
Define and classify COPD utilizing the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.
Explain the role of spirometry and objective lung measurements in the diagnosis of COPD.
Discuss the limitations of spirometry in monitoring response to therapy.
Dr. Fiel discloses that he has received research grants from Genentech. He has participated in advisory boards for GlaxoSmithKline, Chiron, and Altana, and speakers bureaus for GlaxoSmithKline, Chiron, and Boehringer-Ingelheim. He will also be discussing off-label, unapproved and/or investigational uses of medications in this program.
Dr. Sciurba discloses that he has received research grants, consultant fees and speaker’s fees from GlaxoSmithKline. He has received research grants and speaker’s fees from Boehringer-Ingelheim Pharmaceuticals, Inc. He has received research grants from Emphasys Medical, Inc., Abgenix Inc., and Otsuka America Pharmaceutical, Inc. He is a consultant for Pfizer Inc, Roche Pharmaceuticals, AstraZeneca, and Amgen, Inc. He will also be discussing off-label, unapproved and/or investigational uses of medications in this program.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Consultant and Medical Communications Media, Incorporated. AKH Consultant is accredited by the ACCME to provide continuing medical education for physicians.
AKH Consultant designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he or she actually spent in the activity.
The release date of this activity is February, 2004. Credit expires December 31, 2005.
This program has been approved for 1.2 hours of continuing nursing education by AKH Consultant. AKH Consultant is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Participants must successfully complete the post-test (70% or higher) and submit an evaluation to receive credit.
Nurse Practitioner CE
This program has been approved for 1.2 hours of continuing education for nurse practitioners by AKH Consultant. AKH Inc. is approved as a provider of nursing and nurse practitioner continuing education by the American Academy of Nurse Practitioners. #030803.
This program (UPN 077-999-04-003-H01) was developed by AKH Consultant and is approved for 1.0 Contact Hour (0.1 CEU). AKH Consultant is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Credit expiration date is December 31, 2005. A Statement of Credit will be awarded upon submission of the post-test with a minimum score of 70%.
AAPA accepts Category I CME credit for the PRA from organizations accredited by ACCME. All programs on cmecorner.com which carry ACCME Category I CME credit are acceptable towards the PA Category I (Preapproved) CME requirement.
PAs requesting credit should check the “Physician” box on the post-test.
Commercial Support Statements
This program has been made possible by an unrestricted educational grant from GlaxoSmithKline.
Click on the "Start program" icon.
The next screen will permit you to check for or download the Flash player required to run this program. You will also find buttons which will permit you to start the program presentation, access other program elements, and take the post-test.
Clicking on "start the program" on this screen will begin the program presentation which will take approximately 1 hour to complete.
You must be registered with cmecorner.com in order to complete the post-test. When you click on the post-test button you will be brought to a screen which will confirm your registration status and provide an opportunity to register if you haven't done so previously.
Instructions for completing and submitting the post-test are provided on the post-test screen. A minimum score of 70% on the post-test is required for a CME or CE certificate.
The information contained in this program does not necessarily reflect the opinions or recommendations of GlaxoSmithKline, AKH Consultant, or Medical Communications Media, Inc. Diagnostic procedures or treatments discussed in the program should not be utilized by clinicians without evaluation of patients’ conditions and possible contraindications or risks, and without a review of applicable manufacturer’s product information and comparison with recommendations of other authorities.